Joanna Wiensch
Stock Analyst at Citigroup
(2.56)
# 2,371
Out of 5,090 analysts
30
Total ratings
71.43%
Success rate
7.9%
Average return
Main Sectors:
Stocks Rated by Joanna Wiensch
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BDX Becton, Dickinson and Company | Downgrades: Neutral | $217 → $185 | $193.96 | -4.62% | 7 | May 22, 2025 | |
| ABT Abbott Laboratories | Maintains: Buy | $119 → $127 | $125.08 | +1.54% | 8 | Aug 22, 2024 | |
| DXCM DexCom | Maintains: Buy | $83 → $90 | $65.49 | +37.81% | 2 | Apr 29, 2020 | |
| COO The Cooper Companies | Maintains: Neutral | $90 → $80 | $81.40 | -2.33% | 2 | Mar 27, 2020 | |
| IRTC iRhythm Technologies | Initiates: Buy | $120 | $178.37 | -32.72% | 1 | Mar 5, 2020 | |
| PEN Penumbra | Initiates: Buy | $200 | $300.66 | -33.48% | 1 | Mar 5, 2020 | |
| GKOS Glaukos | Initiates: Sell | $40 | $108.51 | -63.14% | 1 | Mar 5, 2020 | |
| ZBH Zimmer Biomet Holdings | Initiates: Buy | $168 | $94.28 | +78.19% | 1 | Mar 5, 2020 | |
| ALC Alcon | Initiates: Neutral | $63 | $80.73 | -21.96% | 1 | Mar 5, 2020 | |
| SYK Stryker | Initiates: Buy | $235 | $364.02 | -35.44% | 1 | Mar 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $220 | $304.49 | -27.75% | 1 | Mar 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $84 | $86.19 | -2.54% | 1 | Mar 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $94 | $18.54 | +407.01% | 1 | Mar 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $163 | $201.93 | -19.28% | 1 | Mar 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $124 | $101.36 | +22.34% | 1 | Mar 5, 2020 |
Becton, Dickinson and Company
May 22, 2025
Downgrades: Neutral
Price Target: $217 → $185
Current: $193.96
Upside: -4.62%
Abbott Laboratories
Aug 22, 2024
Maintains: Buy
Price Target: $119 → $127
Current: $125.08
Upside: +1.54%
DexCom
Apr 29, 2020
Maintains: Buy
Price Target: $83 → $90
Current: $65.49
Upside: +37.81%
The Cooper Companies
Mar 27, 2020
Maintains: Neutral
Price Target: $90 → $80
Current: $81.40
Upside: -2.33%
iRhythm Technologies
Mar 5, 2020
Initiates: Buy
Price Target: $120
Current: $178.37
Upside: -32.72%
Penumbra
Mar 5, 2020
Initiates: Buy
Price Target: $200
Current: $300.66
Upside: -33.48%
Glaukos
Mar 5, 2020
Initiates: Sell
Price Target: $40
Current: $108.51
Upside: -63.14%
Zimmer Biomet Holdings
Mar 5, 2020
Initiates: Buy
Price Target: $168
Current: $94.28
Upside: +78.19%
Alcon
Mar 5, 2020
Initiates: Neutral
Price Target: $63
Current: $80.73
Upside: -21.96%
Stryker
Mar 5, 2020
Initiates: Buy
Price Target: $235
Current: $364.02
Upside: -35.44%
Mar 5, 2020
Initiates: Buy
Price Target: $220
Current: $304.49
Upside: -27.75%
Mar 5, 2020
Initiates: Buy
Price Target: $84
Current: $86.19
Upside: -2.54%
Mar 5, 2020
Initiates: Neutral
Price Target: $94
Current: $18.54
Upside: +407.01%
Mar 5, 2020
Initiates: Buy
Price Target: $163
Current: $201.93
Upside: -19.28%
Mar 5, 2020
Initiates: Buy
Price Target: $124
Current: $101.36
Upside: +22.34%